Elevated Ki-67 expression correlates with poor prognosis and advanced clinicopathological features in most cancers and can serve as a biomarker for disease management (Jing et al., 2019; Li et al., 2021c; Xie et al., 2017). Here, MKI67 is linked to cancer.